Literature DB >> 3244387

Novel halogenated dihydropyridine derivatives with high vascular selectivity.

U Fricke1, W Klaus, B Stein.   

Abstract

Calcium channel antagonists of the dihydropyridine type exhibit preferential vasodilator properties. To study whether this vascular selectivity is due to distinct steric modifications or may be influenced by the physicochemical nature of these drugs, contractility in guinea pig heart isolated papillary muscles, vasodilator properties in isolated rabbit femoral arteries and the lipophilicity of some novel halogenated dihydropyridines have been examined. All newly synthesized derivatives exhibited dose-dependent negative inotropic and vasodilator effects. The negative inotropic potency of all the halogenated derivatives was weaker than that of the parent compound nitrendipine. In contrast, compared to nitrendipine the vasodilator potency of the ester substituted derivatives was slightly increased, while halogen substitution in position 2 and 6 of the dihydropyridine nucleus decreased the vasodilator potency. As a result of the different influence on cardiac and vascular smooth muscle an improved vascular selectivity of the drugs was attained. The ester-substituted dihydropyridine derivatives showed a 9 times (3-bromoethyl-nitrendipine) or 11 times (3-chloroethyl-nitrendipine) higher vascular selectivity with respect to nitrendipine. Correlation of the lipophilicity with the physiological properties showed an increase in biological activity with decreasing lipophilicity. Within the ester-halogenated dihydropyridine derivatives an inverse trend was observed (increasing vasodilation with increasing lipophilicity), indicating a different influence of lipophilicity with the ester-substituted compounds on the different tissues examined. The improved vascular selectivity of the novel halogenated dihydropyridines may be at least in part a consequence of the different lipophilicity of the drugs. In addition, differences in the binding affinities of the dihydropyridines subordinate to distinct voltage dependent conformation states of the calcium channel may contribute.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244387     DOI: 10.1007/bf00172126

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Ionic currents in the guinea-pig taenia coli.

Authors:  H Inomata; C Y Kao
Journal:  J Physiol       Date:  1976-02       Impact factor: 5.182

2.  Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.

Authors:  R B Rogart; A deBruyn Kops; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Conformational features of calcium channel agonist and antagonist analogs of nifedipine.

Authors:  D A Langs; D J Triggle
Journal:  Mol Pharmacol       Date:  1985-05       Impact factor: 4.436

4.  Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site.

Authors:  D G Rhodes; J G Sarmiento; L G Herbette
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

Review 5.  Studies on mechanisms of calcium channel modulators.

Authors:  A Schwartz
Journal:  J Mol Cell Cardiol       Date:  1987-05       Impact factor: 5.000

6.  Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation.

Authors:  D Hafner; E Heinen; E Noack
Journal:  Arzneimittelforschung       Date:  1977

7.  Structure-activity studies on nifedipine in isolated cardiac muscle.

Authors:  R Rodenkirchen; R Bayer; R Steiner; F Bossert; H Meyer; E Möller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

8.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

9.  [The influence of the ester function on the vasodilating activity of 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-pyridine-3,5-dicarboxylates (author's transl)].

Authors:  F Bossert; H Horstmann; H Meyer; W Vater
Journal:  Arzneimittelforschung       Date:  1979

10.  Calcium current-dependent and voltage-dependent inactivation of calcium channels in Helix aspersa.

Authors:  A M Brown; K Morimoto; Y Tsuda; D L wilson
Journal:  J Physiol       Date:  1981-11       Impact factor: 5.182

View more
  3 in total

1.  The influence of endothelium on the action of PGF2 alpha and some dihydropyridine-type calcium antagonists in porcine basilar arteries.

Authors:  G Kojda; W Klaus; G Werner; U Fricke
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

2.  Intervascular and stimulus selectivity of nitrendipine and related derivatives in KCl and prostaglandin F2 alpha precontracted porcine arteries.

Authors:  G Kojda; W Klaus; G Werner; U Fricke
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

3.  Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle.

Authors:  G Werner; W Klaus; G Kojda; U Fricke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.